Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00452582 · ClinicalTrials.gov registry record · Phase 1
Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
A Phase 1 study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00452582: Clinical Trial Phase 1 study, sponsored by Henry Ford Health System.
NCT00452582 is a Phase 1 study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00452582, a Phase 1 study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Stroke is the third leading cause of death in the United States and the leading cause of serious long-term disability. Approximately 50% of the 750,000 people affected by stroke each year have residual physical impairment. Treatment options for recovery are limited at this time. Sildenafil (Viagra) has demonstrated the capability of significantly improving recovery in several animal experiments of stroke. This study is aiming to establish the safety of treatment with sildenafil in people with stroke with the ultimate aim of testing its usefulness to improve recovery.
Interventions
- OTHER Usual care
- DRUG Sildenafil (Viagra)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-04 |
| Phase | Phase 1 |
Why NCT00452582 stopped before completion
NCT00452582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT00452582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00452582 about?
NCT00452582 is a clinical study titled "Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke". Stroke is the third leading cause of death in the United States and the leading cause of serious long-term disability. Approximately 50% of the 750,000 people affected by stroke each year have residual physical impairment. Treatment options for recovery are limited at this time. Sildenafil (Viagra) ...
What is the current status of trial NCT00452582?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-04.
What interventions are being tested in trial NCT00452582?
The interventions under investigation include: Usual care (OTHER), Sildenafil (Viagra) (DRUG).
Who is sponsoring clinical trial NCT00452582?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00452582's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia